IP Library Granted Patent US 7,153,822
Granted Patent B2
US 7,153,822 · App. 10/353,549 · Granted Dec 26, 2006

Compositions and methods for modulating connexin hemichannels

Assignee: Wyeth
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,153,822
App. No.
10/353,549
Granted
Dec 26, 2006
Kind
B2
Abstract

Disclosed are compositions and methods for modulating hemichannel function in a cell, tissue or organ. The invention also relates to useful screens for detecting such compounds, particularly those capable of modulating connexin phosphorylation. Further provided are therapeutic methods for preventing or treating conditions impacted by undesired hemichannel function in a mammal such as heart arrhythmia.

Claims (22)

1. A method of modulating a hemichannel in a cell, tissue or organ exposed to stress, the method comprising contacting the stressed cell, tissue or organ with a therapeutically effective amount of at least one compound selected from the group consisting of compounds represented as Formula I or II, wherein the contact is sufficient to modulate the hemichannel in the stressed cell, tissue or organ, wherein Formula I is defined as follows:

wherein

R 1 represents H or acetyl (Ac)

R 2 represents a sidechain of one of the amino acids Gly, Tyr, D -Tyr, Phe and D -Phe,

R 3 represents any amino acid sidechain,

R 4 represents a sidechain of one of the amino acids Gly, Tyr, D -Tyr, Phe and D -Phe,

R 5 represents OH or NH 2 ,

and a, S, T, P and Q are integers and independently=0 or 1;

and salts thereof,

and wherein Formula II is defined as follows:

R1-X1-X2-X3-R2

wherein,

X1 is 0, Ala, Gly, β-Ala, Tyr, D -Tyr, Asp,

X2 is 0, Ala-Gly-T4c-Pro, Ala-Sar-Hyp-Pro, Ala-Asn, D -Asn- D -Ala, D -Asn, Gly, Ala, D -Ala, β-Ala, Asn or,

X3 is Tyr, D -Tyr, Gly or Phe, and

R1 is H or Ac,

R2 is OH or NH 2 ,

with the proviso that X1 and X2 are not both 0;

and salts thereof.

2. The method of claim 1 , wherein the modulating of the hemichannel is selected from the group comprising closing the hemichannel and opening the hemichannel.

3. The method of claim 2 , wherein the method further comprises phosphorylating a tyrosine residue of connexin 43 (Cx 43) and closing the hemichannel.

4. The method of claim 2 , wherein the method further comprises dephosphorylating a serine residue of connexin 43 (Cx 43) and opening the hemichannel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2004
From: ZEALAND PHARMA A/S
To: WYETH
Reel/Frame 015036/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2003
From: JENSEN, PETER HOLME; LARSEN, BJARNE DUE; HANSEN, LARS BO LAURENBORG; PETERSEN, JORGEN SOBERG; NEVE, SOREN; NIELSEN, MORTEN SCHAK; MEIER, EDDI; STEINESS, EVA
To: ZEALAND PHARMA A/S
Reel/Frame 014163/0037 →
Continuity (2)
Provisional Application 6035271700 · Jan 29, 2002
Related Publication 20040092429A1 · May 13, 2004